{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:06:23Z","timestamp":1790867183536,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T00:00:00Z","timestamp":1720828800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaci-inpractice.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jaip.2024.06.047","type":"journal-article","created":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T16:31:09Z","timestamp":1720283469000},"page":"2268-2277","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Delayed Skin Testing for Systemic Medications: Helpful or Not?"],"prefix":"10.1016","volume":"12","author":[{"given":"Annick","family":"Barbaud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarida","family":"Goncalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Mockenhaupt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Copaescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2024.06.047_bib1","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1111\/all.15889","article-title":"Nomenclature of allergic diseases and hypersensitivity reactions: adapted to modern needs: an EAACI position paper","volume":"78","author":"Jutel","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.06.047_bib2","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jaip.2017.01.025","article-title":"Severe delayed cutaneous and systemic reactions to drugs: a global perspective on the science and art of current practice","volume":"5","author":"Peter","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.06.047_bib3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41572-024-00514-0","article-title":"Severe cutaneous adverse reactions","volume":"10","author":"Hung","year":"2024","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jaip.2024.06.047_bib4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.iac.2022.01.005","article-title":"Recognizing drug hypersensitivity in pigmented skin","volume":"42","author":"Lehloenya","year":"2022","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2024.06.047_bib5","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jaci.2018.10.030","article-title":"Controversies in drug allergy: testing for delayed reactions","volume":"143","author":"Phillips","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.06.047_bib6","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/cod.12720","article-title":"Long-term reproducibility of positive patch test reactions in patients with non-immediate cutaneous adverse drug reactions to antibiotics","volume":"76","author":"Pinho","year":"2017","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2024.06.047_bib7","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/all.15996","article-title":"EAACI\/ENDA position paper on drug provocation testing","volume":"79","author":"Barbaud","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.06.047_bib8","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.jaci.2022.08.028","article-title":"Drug allergy: a 2022 practice parameter update","volume":"150","author":"Khan","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.06.047_bib9","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1016\/j.jaip.2020.07.005","article-title":"Delabeling delayed drug hypersensitivity: how far can you safely go?","volume":"8","author":"Lehloenya","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.06.047_bib10","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jaip.2020.08.012","article-title":"Early high-dose intravenous corticosteroids rapidly arrest Stevens Johnson syndrome and drug reaction with eosinophilia and systemic symptoms recurrence on drug re-exposure","volume":"9","author":"Lehloenya","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.06.047_bib11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/cod.12432","article-title":"European Society of Contact Dermatitis guideline for diagnostic patch testing - recommendations on best practice","volume":"73","author":"Johansen","year":"2015","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2024.06.047_bib12","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/cod.12269","article-title":"Non-irritant concentrations and amounts of active ingredient in drug patch tests","volume":"71","author":"Brajon","year":"2014","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2024.06.047_bib13","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/cod.14063","article-title":"Skin tests in the work-up of cutaneous adverse drug reactions: a review and update","volume":"86","author":"Barbaud","year":"2022","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2024.06.047_bib14","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jaip.2023.10.021","article-title":"In situ patch test and repeated open application test for fixed drug eruption: a multicenter study","volume":"12","author":"Traineau","year":"2024","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.06.047_bib15","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/bjd.12125","article-title":"A\u00a0multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions","volume":"168","author":"Barbaud","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2024.06.047_bib16","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1600-0536.1996.tb02364.x","article-title":"Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"35","author":"Wolkenstein","year":"1996","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2024.06.047_bib17","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/cod.13462","article-title":"Hypersensitivity to antibiotics in drug reaction with eosinophilia and systemic symptoms (DRESS) from other culprits","volume":"82","author":"Santiago","year":"2020","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2024.06.047_bib18","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/bjd.17835","article-title":"Are drug intradermal tests dangerous to explore cross-reactivity and co-sensitization in DRESS?","volume":"181","author":"Soria","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2024.06.047_bib19","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/cea.13380","article-title":"Can we allow a further intake of drugs poorly suspected as responsible in drug reaction with eosinophilia and systemic symptoms (DRESS)? A study of practice","volume":"49","author":"Desroche","year":"2019","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2024.06.047_bib20","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1016\/j.jaip.2022.07.008","article-title":"Skin testing and drug provocation tests in epidermal necrolysis: a French experience","volume":"10","author":"Roux","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.06.047_bib21","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1034\/j.1600-0536.2001.450601.x","article-title":"European Society of Contact Dermatitis. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions","volume":"45","author":"Barbaud","year":"2001","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2024.06.047_bib22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.0105-4538.2001.00001.x-i8","article-title":"General considerations for skin test procedures in the diagnosis of drug hypersensitivity","volume":"57","author":"Brockow","year":"2002","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.06.047_bib23","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.iac.2022.01.003","article-title":"Skin testing approaches for immediate and delayed hypersensitivity reactions","volume":"42","author":"Barbaud","year":"2022","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2024.06.047_bib24","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/QAD.0b013e3282f7cb60","article-title":"A\u00a0review of drug patch testing and implications for HIV clinicians","volume":"22","author":"Shear","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.jaip.2024.06.047_bib26","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3389\/fmed.2020.00156","article-title":"Intradermal tests with drugs: an approach to standardization","volume":"7","author":"Barbaud","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jaip.2024.06.047_bib27","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/all.12142","article-title":"Skin test concentrations for systemically administered drugs \u2013 an ENDA\/EAACI Drug Allergy Interest Group position paper","volume":"68","author":"Brockow","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.06.047_bib28","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jaci.2019.01.045","article-title":"HLA-A\u221732:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms","volume":"144","author":"Konvinse","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.06.047_bib29","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1111\/all.14656","article-title":"Practice parameters for diagnosing and managing iodinated contrast media hypersensitivity","volume":"76","author":"Torres","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.06.047_bib30","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/all.15961","article-title":"Hypersensitivity reactions to proton pump inhibitors. An EAACI position paper","volume":"79","author":"Bavbek","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.06.047_bib32","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.jaip.2020.09.017","article-title":"Criteria for intradermal skin testing and oral challenge in patients labeled as fluoroquinolone allergic","volume":"9","author":"Krantz","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.06.047_bib33","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/01.aids.0000171414.99409.fb","article-title":"Clinical and immunogenetic correlates of abacavir hypersensitivity","volume":"19","author":"Phillips","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.jaip.2024.06.047_bib31","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.jaci.2010.01.052","article-title":"False positive results can occur on delayed reading of intradermal tests with cisplatin","volume":"125","author":"Guyot-Caquelin","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.06.047_bib34","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jaip.2023.09.020","article-title":"Durability of immune responses after drug reaction with eosinophilia and systemic symptoms","volume":"12","author":"Awad","year":"2024","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.06.047_bib35","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1097\/00002030-200211080-00017","article-title":"Utility of patch testing in patients with hypersensitivity syndromes associated with abacavir","volume":"16","author":"Phillips","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.jaip.2024.06.047_bib36","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/all.14122","article-title":"Towards a more precise diagnosis of hypersensitivity to beta-lactams - an EAACI position paper","volume":"75","author":"Romano","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.06.047_bib37","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.jaip.2020.08.006","article-title":"Practical guidance for the evaluation and management of drug hypersensitivity: specific drugs","volume":"8","author":"Broyles","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.06.047_bib38","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/pai.13055","article-title":"Hypersensitivity reactions to antiepileptic drugs in children","volume":"30","author":"Atanaskovic-Markovic","year":"2019","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2024.06.047_bib39","doi-asserted-by":"crossref","first-page":"6825","DOI":"10.2174\/1381612822666161013092339","article-title":"Systemic allergy to corticosteroids: clinical features and cross reactivity","volume":"22","author":"Barbaud","year":"2016","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jaip.2024.06.047_bib40","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/cod.14090","article-title":"Patch testing in drug reaction with eosinophilia and systemic symptoms (DRESS): a literature review","volume":"86","author":"de Groot","year":"2022","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2024.06.047_bib41","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jaip.2022.09.011","article-title":"Utility and safety of skin tests in drug reaction with eosinophilia and systemic symptoms (DRESS): a systematic review","volume":"11","author":"Teo","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.06.047_bib42","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jaci.2022.12.005","article-title":"Updates on the immunopathology and genomics of severe cutaneous adverse drug reactions","volume":"151","author":"Gibson","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.06.047_bib43","doi-asserted-by":"crossref","first-page":"654190","DOI":"10.3389\/fimmu.2021.654190","article-title":"Skin resident memory T cells may play critical role in delayed-type drug hypersensitivity reactions","volume":"12","author":"Schunkert","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2024.06.047_bib44","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0091-6749(03)01624-5","article-title":"IFN-gamma-producing effector CD8+ T cells and IL-10-producing regulatory CD4+ T cells in fixed drug eruption","volume":"112","author":"Teraki","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.06.047_bib45","doi-asserted-by":"crossref","first-page":"e770","DOI":"10.1111\/jdv.18290","article-title":"Patch testing in fixed drug eruptions: a 12-year retrospective study","volume":"36","author":"Calvao","year":"2022","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2024.06.047_bib46","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaip.2017.11.023","article-title":"SJS\/TEN 2017: building multidisciplinary networks to drive science and translation","volume":"6","author":"White","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.06.047_bib47","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/cod.13351","article-title":"Clinical features, culprit drugs, and allergology workup in 41 cases of fixed drug eruption","volume":"81","author":"Ben Fadhel","year":"2019","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2024.06.047_bib48","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1600-0536.2011.01946.x","article-title":"Patch testing in fixed drug eruptions\u2013a 20-year review","volume":"65","author":"Andrade","year":"2011","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2024.06.047_bib49","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1600-0536.1994.tb01900.x","article-title":"Topical provocation of fixed drug eruption. A study of 30 patients","volume":"31","author":"Alanko","year":"1994","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2024.06.047_bib50","first-page":"736","article-title":"Fixed drug eruption and intradermal provocation tests","volume":"18","author":"Mahboob","year":"2008","journal-title":"J\u00a0Coll Physicians Surg Pak"},{"key":"10.1016\/j.jaip.2024.06.047_bib51","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/phpp.12721","article-title":"Contribution of phototesting in the diagnosis of photodermatoses: retrospective study of 100 cases","volume":"38","author":"Pralong","year":"2022","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.jaip.2024.06.047_bib52","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/cod.14297","article-title":"Shedding a light on the importance of photopatch testing: a 12-year experience in a dermatology unit","volume":"88","author":"Codeco","year":"2023","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2024.06.047_bib53","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1468-3083.2004.01053.x","article-title":"Photopatch testing: a consensus methodology for Europe","volume":"18","author":"Bruynzeel","year":"2004","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2024.06.047_bib54","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.annder.2012.03.017","article-title":"Does hypersensitivity to multiple drugs really exist? [in French]","volume":"139","author":"Studer","year":"2012","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.jaip.2024.06.047_bib55","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1016\/j.jaip.2021.02.060","article-title":"DRESS and AGEP reactions to iodinated contrast media: a French case series","volume":"9","author":"Soria","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.06.047_bib56","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1468-3083.2011.04418.x","article-title":"A\u00a0patch testing and cross-sensitivity study of carbamazepine-induced severe cutaneous adverse drug reactions","volume":"27","author":"Lin","year":"2013","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2024.06.047_bib57","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/cod.12155","article-title":"Severe recurrence of drug rash with eosinophilia and systemic symptoms syndrome secondary to rifampicin patch testing in a human immunodeficiency virus-infected man","volume":"70","author":"Shebe","year":"2014","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2024.06.047_bib58","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1600-0536.2011.01888.x","article-title":"Patch, prick or intradermal tests to detect delayed hypersensitivity to corticosteroids?","volume":"64","author":"Soria","year":"2011","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2024.06.047_bib59","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1086\/529382","article-title":"High sensitivity of human leukocyte antigen-b\u22175701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients","volume":"46","author":"Saag","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2024.06.047_bib60","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1056\/NEJMoa0706135","article-title":"HLA-B\u22175701 screening for hypersensitivity to abacavir","volume":"358","author":"Mallal","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2024.06.047_bib61","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/cod.12878","article-title":"First case report of acute generalized exanthematous pustulosis (AGEP) caused by gadolinium confirmed by patch testing","volume":"78","author":"Bordel Gomez","year":"2018","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2024.06.047_bib62","first-page":"155","article-title":"Pustular psoriasis and drug-induced pustulosis","volume":"146","author":"Serra","year":"2011","journal-title":"G\u00a0Ital Dermatol Venereol"},{"key":"10.1016\/j.jaip.2024.06.047_bib63","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s12016-022-08924-2","article-title":"The role of patch testing in evaluating delayed hypersensitivity reactions to medications","volume":"62","author":"Woodruff","year":"2022","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaip.2024.06.047_bib64","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.anai.2023.01.006","article-title":"Drug patch testing in Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review","volume":"130","author":"Novack","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.06.047_bib65","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.jaip.2017.09.004","article-title":"The combined utility of ex\u00a0vivo IFN-gamma release enzyme-linked ImmunoSpot assay and in\u00a0vivo skin testing in patients with antibiotic-associated severe cutaneous adverse reactions","volume":"6","author":"Trubiano","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.06.047_bib66","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jaci.2015.05.050","article-title":"Evolving models of the immunopathogenesis of T cell-mediated drug allergy: the role of host, pathogens, and drug response","volume":"136","author":"White","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219824006901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219824006901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T08:29:06Z","timestamp":1730536146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219824006901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":65,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2213219824006901"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2024.06.047","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Delayed Skin Testing for Systemic Medications: Helpful or Not?","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2024.06.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}